1.
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group
by Luyckx, Valerie A, MBBCh
The Lancet (British edition), 2017, Vol.390 (10092), p.424-428
2.
Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease
by Qiu, Chengxiang
Nature medicine, 2018-11, Vol.24 (11), p.1721-1731
3.
Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy
by Hwang, Subin
Journal of diabetes and its complications, 2017-12, Vol.31 (12), p.1704-1709
4.
Origin and function of myofibroblasts in kidney fibrosis
by LeBleu, Valerie S
Nature medicine, 2013-08, Vol.19 (8), p.1047-1053
5.
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
by Henderson, Neil C
Nature medicine, 2013-12, Vol.19 (12), p.1617-1624
6.
Renal toxicity of therapeutic drugs
by John, R
Journal of clinical pathology, 2009-06, Vol.62 (6), p.505-515
7.
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
by Rowe, Isaline
Nature medicine, 2013-04, Vol.19 (4), p.488-493
8.
Membranoproliferative glomerulonephritis
by Alchi, Bassam
Pediatric nephrology (Berlin, West), 2009-11-12, Vol.25 (8), p.1409-1418
9.
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
by Brooks, Craig R
Nature medicine, 2010-05, Vol.16 (5), p.535-543
10.
Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka
by Nanayakkara, Shanika
Environmental health and preventive medicine, 2012-05, Vol.17 (3), p.213-221
11.
Cellular maintenance and repair of the kidney
by Guo, Jian-Kan
Annual review of physiology, 2010, Vol.72 (1), p.357-376
12.
Characterization of Kidney and Skeleton Phenotypes of Mice Double Heterozygous for Foxc1 and Foxc2
by Motojima, Masaru
Cells, tissues, organs, 2016-06, Vol.201 (5), p.380-389
13.
Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress
by Friederich-Persson, Malou
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.914-919
14.
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
by Seyberth, Hannsjörg W
Pediatric nephrology (Berlin, West), 2011-10-01, Vol.26 (10), p.1789-1802
15.
Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature
by Usui, Joichi, MD, PhD
Human pathology, 2014, Vol.45 (9), p.1918-1927
16.
A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy
by Hoshino, Junichi
American journal of nephrology, 2015-07, Vol.41 (4-5), p.337-344
17.
Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice
by Arai, Satoko
Nature medicine, 2016-02, Vol.22 (2), p.183-193
18.
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
by Kang, Hyun Mi
Nature medicine, 2015-01, Vol.21 (1), p.37-46
19.
Chronic kidney disease: the global challenge
by El Nahas, A Meguid
Lancet, 2005-01-22, Vol.365 (9456), p.331-340
20.
Methylmalonic acidemia: A megamitochondrial disorder affecting the kidney
by Zsengellér, Zsuzsanna K
Pediatric nephrology (Berlin, West), 2014-05-28, Vol.29 (11), p.2139-2146
